Taiwan's FDA logs 63 suspected GLP-1 adverse reactions this year and warns against misuse
_Image credit: Taiwan News_
Taiwan's Food and Drug Administration has received 63 reports of suspected adverse reactions to GLP-1 injections in 2026, 39 of them involving weight-loss products, most often gut problems, low blood sugar and nausea, plus some cases of bowel obstruction and pancreatitis. It stressed the jabs are prescription-only, and diabetes educators are drawing up guidance with Japan and South Korea on anaesthesia risks from slowed stomach emptying.
Source: Taiwan News (8 Nov 2026). Image: Taiwan News.